Circulating tumor DNA analysis (ctDNA) for genomic testing in NSCLC patients with isolated CNS progression.

被引：0
|
作者：
Aldea, Mihaela
Mezquita, Laura
Hendriks, Lizza
Auclin, Edouard
Remon, Jordi
Planchard, David
Jovelet, Cecile
Carlos Benitez, Jose
Gazzah, Anas
Lavaud, Pernelle
Naltet, Charles
Lacroix, Ludovic
Morris, Clive D.
Green, Emma
Howarth, Karen
Nicotra, Claudio
Besse, Benjamin
机构：
[1] Gustave Roussy, Med Oncol Dept, Villejuif, France
[2] MUMC, Maastricht, Netherlands
[3] Hop Europeen Georges Pompidou, Gastrointestinal Oncol Dept, Paris, France
[4] CIOCC Barcelona HM Delfos, Barcelona, Spain
[5] Gustave Roussy, Thorac Grp, Med Oncol Dept, Villejuif, France
[6] Gustave Roussy, Translat Reseach Lab, Villejuif, France
[7] Hosp Univ Mutua Terrassa, Barcelona, YT, Spain
[8] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France
[9] Gustave Roussy, Translat Res, Villejuif, France
[10] Inivata, Cambridge, Cheshire, England
[11] Inivata Ltd, Cambridge, England
[12] Paris Sud Univ, Orsay, France
[13] Gustave Roussy, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.2015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2015
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical and genomic correlates of plasma circulating tumor DNA (ctDNA) tumor fraction (TF) in patients with advanced NSCLC
    dall'Olio, F. G.
    Vasseur, D.
    Mamann, A.
    Garcia, C. A.
    Beshiri, K.
    Marinello, A.
    Tagliamento, M.
    Ghigna, M. R.
    Aldea, M.
    Planchard, D.
    Pasquina, L.
    Barlesi, F.
    Italiano, A.
    Madison, R.
    Oxnard, G.
    Besse, B.
    ANNALS OF ONCOLOGY, 2023, 34 : S1192 - S1193
  • [2] Pathway repression in progression on osimertinib therapy in NSCLC via a comprehensive genomic and epigenomic circulating tumor DNA (ctDNA) assay
    Hardin, Aaron
    Bucheit, Leslie
    Das, Amar
    Eagel, Craig
    Eltoukhy, Helmy
    CLINICAL CANCER RESEARCH, 2024, 30 (21)
  • [3] Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with nivolumab
    Passiglia, F.
    Perez, A.
    Listi, A.
    Castiglia, M.
    Musso, E.
    Ancona, C.
    Rizzo, S.
    Alu, M.
    Blasi, L.
    Russo, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [4] CEREBROSPINAL FLUID-DERIVED CIRCULATING TUMOR DNA IS SUPERIOR TO PLASMA IN NSCLC PATIENTS WITH CNS PROGRESSION
    Yang, Hainan
    Wen, Lei
    Zhou, Caicun
    NEURO-ONCOLOGY, 2022, 24 : 22 - 22
  • [5] Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System Progression
    Aldea, Mihaela
    Hendriks, Lizza
    Mezquita, Laura
    Jovelet, Cecile
    Planchard, David
    Auclin, Edouard
    Remon, Jordi
    Howarth, Karen
    Benitez, Jose Carlos
    Gazzah, Anas
    Lavaud, Pernelle
    Naltet, Charles
    Lacroix, Ludovic
    de Kievit, Frank
    Morris, Clive
    Green, Emma
    Ngo-Camus, Maud
    Rouleau, Etienne
    Massard, Christophe
    Caramella, Caroline
    Friboulet, Luc
    Besse, Benjamin
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (03) : 383 - 391
  • [6] Analysis of circulating tumor cells (CTC) and circulating tumor DNA (ctDNA) in SCC patients
    Higashi, Yutaro
    Matsumura, Yoshiaki
    Kume, Kenichi
    Beppu, Mahiro
    Sugiura, Tsuyoshi
    CANCER SCIENCE, 2022, 113 : 495 - 495
  • [7] Genomic profiling of metastatic prostate cancer through analysis of circulating tumor DNA (ctDNA).
    Gourdin, Theodore Stewart
    Lilly, Michael B.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [8] Circulating Tumor DNA (ctDNA) Clearance as a Biomarker in Patients With Locally Advanced NSCLC Following Chemoradiation
    Knapp, B.
    Mezquita, L.
    Devarakonda, S.
    Aldea, M.
    Waqar, S.
    Pepin, K.
    Ward, J.
    Botticella, A.
    Howarth, K.
    Knape, C.
    Morris, C.
    Govindan, R.
    Besse, B.
    Morgensztern, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S208 - S208
  • [9] Efficacy of circulating tumor DNA (ctDNA) analysis in the early detection of ovarian cancer progression
    Heo, J.
    Kim, Y. N.
    Lee, J. Y.
    Lee, S. T.
    Shin, S.
    Lee, Y. J.
    Kim, S. W.
    Choi, J. R.
    Kim, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S746 - S746
  • [10] Genomic profiling of circulating tumor DNA (ctDNA) from patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Dagogo-Jack, Ibiayi
    Bernicker, Eric
    Li, Tianhong
    Wang, Victoria
    Ross, Jeffrey S.
    Young, Lauren
    Stephens, Philip J.
    Chung, Jon
    Shaw, Alice Tsang
    Ali, Siraj Mahamed
    Miller, Vincent A.
    Schrock, Alexa Betzig
    Spigel, David R.
    Ou, Sai-Hong Ignatius
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345